Our report documents that loss-of-function mutations in MDH2 are compatible with life and are associated with early-onset severe neurological disease, and the deleterious nature of the identified MDH2 variants has been confirmed by functional assessment in both human cells and a yeast model. This evidence concerns the gene MDH2 and nervous system disorder.